Wall Street Analyst Upgrade Medtronic Plc [MDT]. What else is Wall St. saying

BFRI Stock

Medtronic Plc [NYSE: MDT] closed the trading session at $89.73 on 2025-07-14. The day’s price range saw the stock hit a low of $88.98, while the highest price level was $90.239.

The stocks have a year to date performance of 16.44 percent and weekly performance of 2.35 percent. The stock has been moved at 8.53 percent over the last six months. The stock has performed 1.90 percent around the most recent 30 days and changed 8.71 percent over the most recent 3-months.

If compared to the average trading volume of 7.69M shares, MDT reached to a volume of 8911573 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Medtronic Plc [MDT]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MDT shares is $95.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MDT stock is a recommendation set at 2.17. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Wolfe Research have made an estimate for Medtronic Plc shares, keeping their opinion on the stock as Peer Perform, with their previous recommendation back on June 30, 2025. While these analysts kept the previous recommendation, Leerink Partners raised their target price to Outperform. The new note on the price target was released on June 16, 2025, representing the official price target for Medtronic Plc stock. Previously, the target price had yet another raise from $92 to $107, while Citigroup kept a Buy rating on MDT stock. On October 10, 2024, analysts increased their price target for MDT shares from 98 to 105.

The Price to Book ratio for the last quarter was 2.40, with the Price to Cash per share for the same quarter was set at 7.00. Price to Free Cash Flow for MDT in the course of the last twelve months was 22.17 with Quick ratio for the last quarter at 1.42.

MDT stock trade performance evaluation

Medtronic Plc [MDT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.35. With this latest performance, MDT shares gained by 1.90% in over the last four-week period, additionally plugging by 8.53% over the last 6 months – not to mention a rise of 12.33% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MDT stock in for the last two-week period is set at 64.64, with the RSI for the last a single of trading hit 1.52, and the three-weeks RSI is set at 1.52 for Medtronic Plc [MDT]. The present Moving Average for the last 50 days of trading for this stock 85.82, while it was recorded at 89.33 for the last single week of trading, and 87.07 for the last 200 days.

Medtronic Plc [MDT]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Medtronic Plc [MDT] shares currently have an operating margin of 18.38% and a Gross Margin at 59.79%. Medtronic Plc’s Net Margin is presently recorded at 13.90%.

Return on Equity for this stock inclined to 5.13%, with Return on Assets sitting at 5.13%.

Earnings per share (EPS) analysis for Medtronic Plc [MDT] stock

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MDT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Medtronic Plc go to 5.52%.

Medtronic Plc [MDT]: Institutional Ownership

There are presently around $86.84%, or 87.07% of MDT stock, in the hands of institutional investors. The top three institutional holders of MDT stocks are: VANGUARD GROUP INC with ownership of 126.61 million shares, which is approximately 9.7895%. BLACKROCK INC., holding 111.89 million shares of the stock with an approximate value of $$8.81 billion in MDT stocks shares; and BLACKROCK INC., currently with $$4.78 billion in MDT stock with ownership which is approximately 4.6556%.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.